The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company), Takeda, Karyopharm Therapeutics and MorphoSys. The supporters have no influence over the production of the content.
Welcome to The Hodgkin Lymphoma (HL) Channel
VJHemOnc brings you the most impactful updates and insights in the field of HL, directly from world-renowned researchers. In addition to video interviews on key presentations and abstracts from major international congresses, you can explore our ever-growing selection of podcasts, roundtable discussions and more to stay up-to-date on criticial updates in the HL field.
The Hodgkin Lymphoma Channel brings you updates from key clinical trials of CAR-T & cellular therapies, immunotherapies and novel combination regimens for the treatment of HL. Findings from studies of real-world data and research identifying novel biomarkers are presented, as well as commentary on the impact of novel therapies and considerations for integration into daily clinical practice.
The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company), Takeda, Karyopharm Therapeutics and MorphoSys.
The supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
